The Great Britain is witnessing a growing surge in interest surrounding entheogenic substances. Beyond the common use of psilocybin and LSD, investigators and adventurers are increasingly exploring less-charted territories, particularly this powerful hallucinogen and the nascent cannabinoid, CBG. The evolving movement encompasses clinical trials in